MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Fortress Biotech Inc

Abierto

2.9 -4.61

Resumen

Variación precio

24h

Actual

Mínimo

2.88

Máximo

3.04

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+375.41% upside

Dividendos

By Dow Jones

Próximas Ganancias

12 nov 2025

Fortress Biotech Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 oct 2025, 15:07 UTC

Principales Movimientos del Mercado

Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility

10 mar 2025, 02:12 UTC

Adquisiciones, fusiones, absorciones

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 mar 2025, 02:12 UTC

Adquisiciones, fusiones, absorciones

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 mar 2025, 02:11 UTC

Adquisiciones, fusiones, absorciones

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 mar 2025, 02:11 UTC

Adquisiciones, fusiones, absorciones

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 mar 2025, 02:10 UTC

Adquisiciones, fusiones, absorciones

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 mar 2025, 02:10 UTC

Adquisiciones, fusiones, absorciones

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 mar 2025, 02:06 UTC

Adquisiciones, fusiones, absorciones

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT

Comparación entre iguales

Cambio de precio

Fortress Biotech Inc Esperado

Precio Objetivo

By TipRanks

375.41% repunte

Estimación a 12 meses

Media 14.5 USD  375.41%

Máximo 17 USD

Mínimo 12 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

$

help-icon Live chat